期刊
DIABETES CARE
卷 34, 期 -, 页码 S161-S165出版社
AMER DIABETES ASSOC
DOI: 10.2337/dc11-s212
关键词
-
资金
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Daiichi Sankyo
- Eli Lilly
- Ethicon Endo-Surgery
- Generex Biotechnology
- F. Hoffmann-La Roche
- Janssen-Cilag
- Johnson Johnson
- Novo Nordisk
- Medtronic
- Pfizer
- National Institutes of Health (NIH) [R01-HD40787, R01-HD28016, K24-HD01464]
- National Center for Research Resources (NCRR), a component of NIH [UL1RR0249139]